Archive

Health and biotech startups passed a combined $4T in value in 2021. With record VC investment raised, and more unicorns produced than in any previous 12-month period, we look back…

Psychedelic drugs to treat mental health disorders has been around for decades, but in 2020 this area received the focus of investors with added relevance as the current…

Digital therapeutics (DTx) are playing an increasingly central role in the future of healthcare, by delivering an evidence-based intervention via software or medical device to replace or complement disease treatment.

Despite a blockbuster 2020, health and biotech startups are continuing to smash all records in 2021. In partnership with Emerge GHI, and as Q3 has come to an end,…

Transformation in healthcare has clearly accelerated in the last 18 months. But while immediate attention was on acute clinical solutions for the pandemic, investment being made now has longer term…

That the world of Healthtech and Biotech have seen growth in the last 18 months in perhaps no surprise, but the scale of the shifts in the startup market…